Prostaglandin receptors EP2 and IP are detectable in atherosclerotic arteries and plaques
Prostaglandin receptors EP2 and IP are detectable in atherosclerotic arteries and plaques
About this item
Full title
Author / Creator
Muto, A , Nishibe, T , Miyauchi, Y , Kondo, Y , Yamamoto, Y , Dardik, A and Shigematsu, H
Publisher
Italy: Edizioni Minerva Medica
Journal title
Language
English
Formats
Publication information
Publisher
Italy: Edizioni Minerva Medica
Subjects
More information
Scope and Contents
Contents
Prostaglandin (PG) receptor agonists are frequently used for the pharmacological treatment of arteriosclerosis obliterans (ASO). In particular, the PG receptors EP2 and IP stimulate vasodilation and inhibit platelet aggregation, biological processes thought to be protective against ASO and important for physiological homeostasis. However it is unce...
Alternative Titles
Full title
Prostaglandin receptors EP2 and IP are detectable in atherosclerotic arteries and plaques
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733645649
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733645649
Other Identifiers
ISSN
0392-9590
E-ISSN
1827-1839
